Literature DB >> 21839507

Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide.

Wen Zhang1, Zhouyi Guo, Deqiu Huang, Zhiming Liu, Xi Guo, Huiqing Zhong.   

Abstract

Graphene has shown great potential both in photothermal therapy and drug delivery. Herein, we developed doxorubicin-loaded PEGylated nanographene oxide (NGO-PEG-DOX) to facilitate combined chemotherapy and photothermal therapy in one system. In this work, we studied the ablation of tumor both in vivo and in vitro by the combination of photothermal therapy and chemotherapy using this functional graphene oxide. The ability of the NGO-PEG-DOX nanoparticle to combine the local specific chemotherapy with external near-infrared (NIR) photothermal therapy significantly improved the therapeutic efficacy of cancer treatment. Compared with chemotherapy or photothermal therapy alone, the combined treatment demonstrated a synergistic effect, resulting in higher therapeutic efficacy. Furthermore, lower systematic toxicity of NGO-PEG-DOX than DOX was proved by the pathologic examination of main organs in our toxicity study.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839507     DOI: 10.1016/j.biomaterials.2011.07.071

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  108 in total

Review 1.  Review of the progress toward achieving heat confinement-the holy grail of photothermal therapy.

Authors:  Wangzhong Sheng; Sha He; William J Seare; Adah Almutairi
Journal:  J Biomed Opt       Date:  2017-08-01       Impact factor: 3.170

2.  Photothermal enhancement of chemotherapy mediated by gold-silica nanoshell-loaded macrophages: in vitro squamous cell carcinoma study.

Authors:  Steen J Madsen; En-Chung Shih; Qian Peng; Catherine Christie; Tatiana Krasieva; Henry Hirschberg
Journal:  J Biomed Opt       Date:  2016-01       Impact factor: 3.170

3.  Preparation and functionalization of graphene nanocomposites for biomedical applications.

Authors:  Kai Yang; Liangzhu Feng; Hao Hong; Weibo Cai; Zhuang Liu
Journal:  Nat Protoc       Date:  2013-11-07       Impact factor: 13.491

4.  Influence of hyperthermia on efficacy and uptake of carbon nanohorn-cisplatin conjugates.

Authors:  Matthew R DeWitt; Allison M Pekkanen; John Robertson; Christopher G Rylander; Marissa Nichole Rylander
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

5.  Long circulating reduced graphene oxide-iron oxide nanoparticles for efficient tumor targeting and multimodality imaging.

Authors:  Cheng Xu; Sixiang Shi; Liangzhu Feng; Feng Chen; Stephen A Graves; Emily B Ehlerding; Shreya Goel; Haiyan Sun; Christopher G England; Robert J Nickles; Zhuang Liu; Taihong Wang; Weibo Cai
Journal:  Nanoscale       Date:  2016-04-25       Impact factor: 7.790

6.  In vivo compatibility of graphene oxide with differing oxidation states.

Authors:  Stefanie A Sydlik; Siddharth Jhunjhunwala; Matthew J Webber; Daniel G Anderson; Robert Langer
Journal:  ACS Nano       Date:  2015-04-10       Impact factor: 15.881

Review 7.  Recent advances in graphene-based nanomaterials: properties, toxicity and applications in chemistry, biology and medicine.

Authors:  Jun Yao; Heng Wang; Min Chen; Mei Yang
Journal:  Mikrochim Acta       Date:  2019-06-01       Impact factor: 5.833

8.  Diagnostic and Therapeutic Nanomedicine.

Authors:  Jinmyoung Joo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Modality switching between therapy and imaging based on the excitation wavelength dependence of dual-function agents in folic acid-conjugated graphene oxides.

Authors:  Seung Won Jun; Junyoung Kwon; Soo Kyung Chun; Hyun Ah Lee; Jaebeom Lee; Dae Youn Hwang; Chen-Yuan Dong; Chang-Seok Kim
Journal:  Biomed Opt Express       Date:  2018-01-22       Impact factor: 3.732

10.  Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.

Authors:  Raj Kumar Thapa; Yongjoo Choi; Jee-Heon Jeong; Yu Seok Youn; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Pharm Res       Date:  2016-08-29       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.